Related by context. Frequent words. (Click for all words.) 67 Metastatic Melanoma 65 ThermoDox 65 pertuzumab 64 relapsed refractory multiple myeloma 63 forodesine 63 PEG SN# 62 OncoVEX GM CSF 62 superficial bladder cancer 62 ThermoDox ® 61 Pivotal Phase III 61 metastatic hormone refractory 61 relapsing multiple sclerosis 61 phase IIb clinical 60 multi kinase inhibitor 60 KRN# 60 metastatic liver 60 Amrubicin 60 Azedra 60 SABCS 59 metastatic castration resistant 59 gastrointestinal stromal tumors GIST 59 Panzem R 59 IMC A# 59 dose escalation trial 59 acute promyelocytic leukemia APL 59 mRCC 59 refractory multiple myeloma 59 CR# vcMMAE 59 REOLYSIN ® 59 metastatic renal cell carcinoma 58 nonrandomized 58 axitinib 58 Acute Myocardial Infarction 58 chemoradiotherapy 58 mTOR inhibitor 58 HER2 positive metastatic breast 58 oropharyngeal candidiasis 58 placebo controlled clinical 58 Aliskiren 58 Sym# 58 phase IIb 58 multicenter clinical 58 Imprime PGG 58 nab paclitaxel 58 R sorafenib tablets 58 Cloretazine R VNP#M 58 elotuzumab 58 non squamous 58 ganetespib 57 Pivotal Phase 57 stereotactic body 57 prospective multicenter 57 tanespimycin 57 malignant pleural mesothelioma 57 Clinical Trial Results 57 IV melanoma 57 Phase III Clinical Trial 57 bicifadine 57 Phase Ib clinical 57 multiple myeloma MM 57 double blinded placebo 57 Atiprimod 57 olaparib 57 relapsed multiple myeloma 57 Metastatic Colorectal Cancer 57 Patient Enrollment 57 CA4P 57 Carcinoma 57 lymphoma CTCL 57 Acute Myeloid Leukemia 57 colorectal carcinoma 57 Perifosine 56 diabetic neuropathic pain 56 Phase 1b trial 56 glioblastoma multiforme GBM 56 pharmacodynamic effects 56 IIa trial 56 Diabetic Macular Edema 56 TORISEL 56 mycophenolate mofetil 56 placebo controlled Phase 56 deforolimus 56 ponatinib 56 PXD# 56 rNAPc2 56 Pivotal Trial 56 breast carcinoma 56 Randomized controlled 56 bevacizumab Avastin 56 Tesetaxel 56 efficacy tolerability 56 phase IIa 56 aflibercept 56 heavily pretreated 56 PRECISE 56 sapacitabine 56 Phase 2a trial 56 advanced carcinoid 56 PREZISTA r 56 Chronic Lymphocytic Leukemia 56 myeloproliferative disorders